| 1 | G-CSF | [1]  Filgrastim Filgrastim | [1]  Filgrastim 
                
                    Filgrastim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [16]  2 2, 6, 11, 13, 16, 22, 47, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬
 | 
| 2 | G-CSF for Conditioning before HSCT. | [1]  Filgrastim Filgrastim | [1]  Filgrastim 
                
                    Filgrastim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1]  65 65 💬
 | 
| 3 | G02CB03 | - | - | - | - | [1]  75 75 💬
 | 
| 4 | G048E03 | - | - | - | - | [1]  85 85 💬
 | 
| 5 | G04BE03 | - | - | - | - | [1]  86 86 💬
 | 
| 6 | G04BE03- Sildenafil - sildenafil (citrato) | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 7 | G04BE08 | - | - | - | - | [1]  86 86 💬
 | 
| 8 | G04CB02 | - | - | - | - | [1]  2 2 💬
 | 
| 9 | G1117337 | - | - | - | - | [2]  67 67, 299 💬
 | 
| 10 | G1567970 | - | - | - | - | [3]  46 46, 53, 97 💬
 | 
| 11 | G1XCG | - | - | - | - | [1]  65 65 💬
 | 
| 12 | G1XCGD transduced CD34+ cells | - | - | - | - | [1]  65 65 💬
 | 
| 13 | G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process) | - | - | - | - | [1]  13 13 💬
 | 
| 14 | G2019S LRRK2 | - | - | - | - | [1]  6 6 💬
 | 
| 15 | G321605 | - | - | - | - | [3]  85 85, 96, 97 💬
 | 
| 16 | G451990 | - | - | - | - | [2]  51 51, 85 💬
 | 
| 17 | G914167 | - | - | - | - | [1]  299 299 💬
 | 
| 18 | G957389 | - | - | - | - | [1]  299 299 💬
 | 
| 19 | GA | - | - | - | - | [1]  13 13 💬
 | 
| 20 | GA 20 mg/mL | - | - | - | - | [1]  13 13 💬
 | 
| 21 | GA 40 mg/mL | - | - | - | - | [1]  13 13 💬
 | 
| 22 | GA Depot | - | - | - | - | [1]  13 13 💬
 | 
| 23 | GA Depot 25mg once monthly | - | - | - | - | [1]  13 13 💬
 | 
| 24 | GA Depot 40 mg | - | - | - | - | [1]  13 13 💬
 | 
| 25 | GA Depot 40mg once monthly | - | - | - | - | [1]  13 13 💬
 | 
| 26 | GA Depot 80 mg | - | - | - | - | [1]  13 13 💬
 | 
| 27 | Ga-68-DOTA-NOC | - | - | - | - | [1]  84 84 💬
 | 
| 28 | GA-GCB | [1]  Velaglucerase alfa Velaglucerase alfa | [1]  Velaglucerase alfa 
                
                    Velaglucerase alfa
                
             💬
 | [1]  GBA1 GBA1 💬
 | [4]  Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 29 | GA-GCB (velaglucerase alfa) | [1]  Velaglucerase alfa Velaglucerase alfa | [1]  Velaglucerase alfa 
                
                    Velaglucerase alfa
                
             💬
 | [1]  GBA1 GBA1 💬
 | [4]  Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 30 | GABAPENTIN | [1]  Gabapentin Gabapentin | [1]  Gabapentin 
                
                    Gabapentin
                
             💬
 | [5]  CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [5]  6 6, 13, 19, 70, 298 💬
 | 
| 31 | Gabapentin (neurontin® capsule 300mg) treatment | [1]  Gabapentin Gabapentin | [1]  Gabapentin 
                
                    Gabapentin
                
             💬
 | [5]  CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [1]  70 70 💬
 | 
| 32 | Gabapentin prescriptions | [1]  Gabapentin Gabapentin | [1]  Gabapentin 
                
                    Gabapentin
                
             💬
 | [5]  CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [1]  298 298 💬
 | 
| 33 | GABAPENTINA | [1]  Gabapentin Gabapentin | [1]  Gabapentin 
                
                    Gabapentin
                
             💬
 | [5]  CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [1]  6 6 💬
 | 
| 34 | GABAPENTINA KERN PHARMA | [1]  Gabapentin Gabapentin | [1]  Gabapentin 
                
                    Gabapentin
                
             💬
 | [5]  CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [1]  6 6 💬
 | 
| 35 | Gabapentine | [1]  Gabapentin Gabapentin | [1]  Gabapentin 
                
                    Gabapentin
                
             💬
 | [5]  CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [1]  13 13 💬
 | 
| 36 | Gabapentine 300mg | [1]  Gabapentin Gabapentin | [1]  Gabapentin 
                
                    Gabapentin
                
             💬
 | [5]  CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [1]  13 13 💬
 | 
| 37 | Gaboxadol | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2]  201 201, 206 💬
 | 
| 38 | Gaboxadol (HLX-0206) | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  206 206 💬
 | 
| 39 | GABOXADOL MONOHYDRATE | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 40 | Gaboxadol monohydrate 0.5 mg | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 41 | Gaboxadol monohydrate 0.5 mg (intended commercial formulation) | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 42 | Gaboxadol monohydrate 0.5 mg capsule | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 43 | Gaboxadol monohydrate 2 mg | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 44 | Gaboxadol monohydrate 2 mg (intended commercial formulation) | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 45 | Gaboxadol monohydrate 2 mg capsule | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 46 | Gaboxadol monohydrate 5 mg | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 47 | Gaboxadol monohydrate 5 mg (intended commercial formulation) | [1]  Gaboxadol Gaboxadol | [1]  Gaboxadol 
                
                    Gaboxadol
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  201 201 💬
 | 
| 48 | Gadobenate | [1]  Gadobenic acid Gadobenic acid | [1]  Gadobenic acid 
                
                    Gadobenic acid
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 49 | Gadobenate Dimeglumine | [1]  Gadobenic acid Gadobenic acid | [1]  Gadobenic acid 
                
                    Gadobenic acid
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 50 | GADOBUTROL | [1]  Gadobutrol Gadobutrol | [1]  Gadobutrol 
                
                    Gadobutrol
                
             💬
 | - | - | [2]  13 13, 22 💬
 | 
| 51 | Gadodiamide | [1]  Gadodiamide Gadodiamide | [1]  Gadodiamide 
                
                    Gadodiamide
                
             💬
 | - | - | [1]  305 305 💬
 | 
| 52 | Gadolinium | [1]  Gadolinium Gadolinium | - | - | - | [4]  13 13, 34, 46, 65 💬
 | 
| 53 | Gadolinium contrast | [1]  Gadolinium Gadolinium | - | - | - | [1]  34 34 💬
 | 
| 54 | Gadolinium For abdomen | [1]  Gadolinium Gadolinium | - | - | - | [1]  65 65 💬
 | 
| 55 | Gadolinium For lower back | [1]  Gadolinium Gadolinium | - | - | - | [1]  65 65 💬
 | 
| 56 | Gadolinium-based contrast | [1]  Gadolinium Gadolinium | - | - | - | [1]  13 13 💬
 | 
| 57 | Gadoteric acid | [1]  Gadoteric acid Gadoteric acid | [1]  Gadoteric acid 
                
                    Gadoteric acid
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 58 | Gadoteridol | [1]  Gadoteridol Gadoteridol | [1]  Gadoteridol 
                
                    Gadoteridol
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 59 | Gadovist | - | - | - | - | [2]  13 13, 22 💬
 | 
| 60 | GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado | - | - | - | - | [1]  13 13 💬
 | 
| 61 | Gadovist 1.0 mmol/ml Injektionslösung | [1]  Gadobutrol Gadobutrol | [1]  Gadobutrol 
                
                    Gadobutrol
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 62 | Galactose | [1]  Galactose Galactose | [1]  Galactose 
                
                    Galactose
                
             💬
 | - | - | [1]  222 222 💬
 | 
| 63 | Galafold | [1]  Migalastat Migalastat | [1]  Migalastat 
                
                    Migalastat
                
             💬
 | - | - | [1]  19 19 💬
 | 
| 64 | GALANTAMINE | [1]  Galantamine Galantamine | [1]  Galantamine 
                
                    Galantamine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [2]  6 6, 127 💬
 | 
| 65 | Galantamine hydrobromide | [1]  Galantamine Galantamine | [1]  Galantamine 
                
                    Galantamine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [2]  6 6, 127 💬
 | 
| 66 | GALEN® tablet | - | - | - | - | [2]  43 43, 44 💬
 | 
| 67 | GALICAFTOR | [1]  Galicaftor Galicaftor | [1]  Galicaftor 
                
                    Galicaftor
                
             💬
 | [1]  CFTR CFTR 💬
 | [8]  ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1]  299 299 💬
 | 
| 68 | Gallium nitrate | [2]  Gallium nitrate Gallium nitrate, Nitrate | [2]  Gallium nitrate 
                
                    Gallium nitrate
                
            , 
                
                    Nitric acid
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 69 | Gallium-68 DOTATATE | [1]  Dotatate Dotatate | - | - | - | [1]  84 84 💬
 | 
| 70 | Gallium-68-DOTA-N-Octreotide | [1]  Octreotide Octreotide | [1]  Octreotide 
                
                    Octreotide
                
             💬
 | [1]  SSTR2 SSTR2 💬
 | [4]  Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1]  84 84 💬
 | 
| 71 | Gallium68-Dota-Noc | - | - | - | - | [1]  85 85 💬
 | 
| 72 | GALSULFASE | [1]  Galsulfase Galsulfase | [1]  Galsulfase 
                
                    Galsulfase
                
             💬
 | [1]  ARSB ARSB 💬
 | [3]  Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1]  19 19 💬
 | 
| 73 | Gamma Globulin | - | - | - | - | [2]  15 15, 50 💬
 | 
| 74 | Gamma interferon | - | - | - | - | [1]  18 18 💬
 | 
| 75 | Gamma-Linolenic acid | [2]  Gamolenic acid Gamolenic acid, alpha-Linolenic acid | [1]  Gamolenic acid 
                
                    Gamolenic acid
                
             💬
 | - | - | [1]  46 46 💬
 | 
| 76 | Gamma-secretase/Notch signalling pathway inhibitor RO4929097 | - | - | - | - | [1]  74 74 💬
 | 
| 77 | Gamma-Tocopherol | [2]  Tocopherol Tocopherol, gamma-Tocopherol | [1]  Tocopherol 
                
                    Tocopherol
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 78 | GAMMAGARD LIQUID | - | - | - | - | [1]  65 65 💬
 | 
| 79 | Gammagard S/D (Solvent/Detergent) | - | - | - | - | [1]  65 65 💬
 | 
| 80 | Gammaglobulin | - | - | - | - | [1]  65 65 💬
 | 
| 81 | Gammanorm | - | - | - | - | [2]  14 14, 65 💬
 | 
| 82 | Gammanorm 165 mg/mL | - | - | - | - | [1]  65 65 💬
 | 
| 83 | Gammaplex | [1]  Human immunoglobulin G Human immunoglobulin G | - | - | - | [2]  63 63, 65 💬
 | 
| 84 | Gammaplex (5%) | - | - | - | - | [1]  65 65 💬
 | 
| 85 | Gammaplex (Intravenous immunoglobulin) | - | - | - | - | [1]  65 65 💬
 | 
| 86 | Gammaplex 10 | [1]  Human immunoglobulin G Human immunoglobulin G | - | - | - | [1]  65 65 💬
 | 
| 87 | Gammaplex, intravenous immunoglobulin | - | - | - | - | [1]  63 63 💬
 | 
| 88 | GAMUNEX 10% | [1]  Human immunoglobulin G Human immunoglobulin G | - | - | - | [1]  11 11 💬
 | 
| 89 | GAMUNEX-C | - | - | - | - | [1]  65 65 💬
 | 
| 90 | Ganaxalone | - | - | - | - | [1]  158 158 💬
 | 
| 91 | Ganaxolone | [1]  Ganaxolone Ganaxolone | [1]  Ganaxolone 
                
                    Ganaxolone
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [4]  145 145, 152, 158, 206 💬
 | 
| 92 | Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one) | [1]  Ganaxolone Ganaxolone | [1]  Ganaxolone 
                
                    Ganaxolone
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  152 152 💬
 | 
| 93 | Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one) | [1]  Ganaxolone Ganaxolone | [1]  Ganaxolone 
                
                    Ganaxolone
                
             💬
 | [16]  GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
 | [7]  GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1]  152 152 💬
 | 
| 94 | Ganciclovir | [1]  Ganciclovir Ganciclovir | [1]  Ganciclovir 
                
                    Ganciclovir
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 95 | Gandouling | - | - | - | - | [1]  171 171 💬
 | 
| 96 | Ganoderma | - | - | - | - | [1]  6 6 💬
 | 
| 97 | Garadacimab | [1]  Garadacimab Garadacimab | - | - | - | [1]  85 85 💬
 | 
| 98 | Gardasil | [4]  Human papillomavirus type 11 L1 capsid protein antigen Human papillomavirus type 11 L1 capsid protein antigen, Human papillomavirus type 16 L1 capsid protein antigen, Human papillomavirus type 18 L1 capsid protein antigen, Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | [1]  49 49 💬
 | 
| 99 | Garetosmab | [1]  Garetosmab Garetosmab | [1]  Garetosmab 
                
                    Garetosmab
                
             💬
 | - | - | [1]  272 272 💬
 | 
| 100 | Garlic | [1]  Garlic Garlic | [1]  Garlic 
                
                    Garlic
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 101 | Gastro-resistant phosphatidylcholine granules | [1]  Lecithin Lecithin | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 102 | Gastrus | - | - | - | - | [1]  66 66 💬
 | 
| 103 | Gazyvaro | [1]  Obinutuzumab Obinutuzumab | [1]  Obinutuzumab 
                
                    Obinutuzumab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2]  49 49, 222 💬
 | 
| 104 | GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 1000MG/40ML - 1 FLACONCINO | [1]  Obinutuzumab Obinutuzumab | [1]  Obinutuzumab 
                
                    Obinutuzumab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  222 222 💬
 | 
| 105 | GB-0998 | - | - | - | - | [1]  50 50 💬
 | 
| 106 | GB-0998 (Intravenous immunoglobulin) | - | - | - | - | [1]  11 11 💬
 | 
| 107 | GB002 | - | - | - | - | [1]  86 86 💬
 | 
| 108 | GB002 (seralutinib) | - | - | - | - | [1]  86 86 💬
 | 
| 109 | GB002 Capsules | - | - | - | - | [1]  86 86 💬
 | 
| 110 | GB004 | - | - | - | - | [1]  97 97 💬
 | 
| 111 | GB004-HCl | - | - | - | - | [1]  97 97 💬
 | 
| 112 | GB0139 | - | - | - | - | [1]  85 85 💬
 | 
| 113 | GB0139 (previously known as TD139) | - | - | - | - | [1]  85 85 💬
 | 
| 114 | GB224 10mg | - | - | - | - | [1]  46 46 💬
 | 
| 115 | GB224 15mg | - | - | - | - | [1]  46 46 💬
 | 
| 116 | GB224 20mg | - | - | - | - | [1]  46 46 💬
 | 
| 117 | GB224 2mg | - | - | - | - | [1]  46 46 💬
 | 
| 118 | GB224 30mg | - | - | - | - | [1]  46 46 💬
 | 
| 119 | GB224 5mg | - | - | - | - | [1]  46 46 💬
 | 
| 120 | GB242 | - | - | - | - | [1]  46 46 💬
 | 
| 121 | GBP | - | - | - | - | [1]  13 13 💬
 | 
| 122 | GBT440 | - | - | - | - | [1]  85 85 💬
 | 
| 123 | GBT440 300 mg capsule | - | - | - | - | [1]  85 85 💬
 | 
| 124 | GBT440 300 mg tablet | - | - | - | - | [1]  85 85 💬
 | 
| 125 | GC+HCQ | - | - | - | - | [1]  49 49 💬
 | 
| 126 | GC1008 | [1]  Fresolimumab Fresolimumab | [1]  Fresolimumab 
                
                    Fresolimumab
                
             💬
 | [3]  TGFB1 TGFB1, TGFB2, TGFB3 💬
 | [35]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | [2]  85 85, 222 💬
 | 
| 127 | GC1111_0.5mg/kg | - | - | - | - | [1]  19 19 💬
 | 
| 128 | GC1111_1.0mg/kg | - | - | - | - | [1]  19 19 💬
 | 
| 129 | GC1119 | - | - | - | - | [1]  19 19 💬
 | 
| 130 | GC1123 | - | - | - | - | [1]  19 19 💬
 | 
| 131 | GC301 | - | - | - | - | [1]  256 256 💬
 | 
| 132 | GCK 100 mg | - | - | - | - | [1]  46 46 💬
 | 
| 133 | GCK 200 mg | - | - | - | - | [1]  46 46 💬
 | 
| 134 | GCK 300 mg | - | - | - | - | [1]  46 46 💬
 | 
| 135 | Gcsf | - | - | - | - | [1]  65 65 💬
 | 
| 136 | GDC-0134 | [1]  GDC-0134 GDC-0134 | - | - | - | [1]  2 2 💬
 | 
| 137 | GDC-0853 | - | - | - | - | [3]  13 13, 46, 49 💬
 | 
| 138 | GDC-0853 RO7010939 | - | - | - | - | [3]  13 13, 46, 49 💬
 | 
| 139 | GDNF & Synchro Med Infusion System | - | - | - | - | [1]  5 5 💬
 | 
| 140 | GE180 PET Scan | - | - | - | - | [1]  6 6 💬
 | 
| 141 | GED-0301 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 142 | GED-0507-34-LEVO | [1]  GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1]  97 97 💬
 | 
| 143 | GED-0507-34-Levo 160 mg | [1]  GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1]  97 97 💬
 | 
| 144 | GED-0507-34-Levo 80 mg | [1]  GED-0507-34-Levo GED-0507-34-Levo | - | - | - | [1]  97 97 💬
 | 
| 145 | GED0507 | - | - | - | - | [1]  97 97 💬
 | 
| 146 | Gefapixant | [1]  Gefapixant Gefapixant | [1]  Gefapixant 
                
                    Gefapixant
                
             💬
 | [1]  P2RX3 P2RX3 💬
 | [3]  Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Taste transduction 💬 | [2]  85 85, 226 💬
 | 
| 147 | Gefitinib | [1]  Gefitinib Gefitinib | [1]  Gefitinib 
                
                    Gefitinib
                
             💬
 | [1]  EGFR EGFR 💬
 | [48]  Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | [1]  75 75 💬
 | 
| 148 | Gelatin | [1]  Gelatin Gelatin | [2]  Gelatin 
                
                    Gelatin
                
            , 
                
                    Donkey glue
                
             💬
 | - | - | [5]  28 28, 62, 78, 97, 269 💬
 | 
| 149 | Gelatine | [1]  Gelatin Gelatin | [2]  Gelatin 
                
                    Gelatin
                
            , 
                
                    Donkey glue
                
             💬
 | - | - | [1]  19 19 💬
 | 
| 150 | Geleli | - | - | - | - | [1]  46 46 💬
 | 
| 151 | Gemcabene | [1]  Gemcabene Gemcabene | - | - | - | [2]  79 79, 265 💬
 | 
| 152 | Genakumab | - | - | - | - | [1]  107 107 💬
 | 
| 153 | Gene Activated a-Galactosidase A | - | - | - | - | [1]  19 19 💬
 | 
| 154 | Gene Activated Human Glucocerebrosidase | - | - | - | - | [1]  19 19 💬
 | 
| 155 | Gene activated human glucocerebrosidase, velaglucerase alfa | [1]  Velaglucerase alfa Velaglucerase alfa | [1]  Velaglucerase alfa 
                
                    Velaglucerase alfa
                
             💬
 | [1]  GBA1 GBA1 💬
 | [4]  Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 156 | Gene analysis | - | - | - | - | [1]  79 79 💬
 | 
| 157 | Gene sequencing | - | - | - | - | [1]  65 65 💬
 | 
| 158 | Gene therapy | - | - | - | - | [1]  65 65 💬
 | 
| 159 | Gene Therapy Method for CGD | - | - | - | - | [1]  65 65 💬
 | 
| 160 | Gene Therapy product:vMCO-I | - | - | - | - | [1]  90 90 💬
 | 
| 161 | Gene Therapy-vMCO-010 | - | - | - | - | [1]  301 301 💬
 | 
| 162 | Gene transduced PBL and/or gene transduced HSC | - | - | - | - | [1]  65 65 💬
 | 
| 163 | Gene-Activated Human Glucocerebrosidase | - | - | - | - | [1]  19 19 💬
 | 
| 164 | Gene-Activated Human Glucocerebrosidase 200U/vial | - | - | - | - | [1]  19 19 💬
 | 
| 165 | Gene-Activated Human Glucocerebrosidase 400U/vial | - | - | - | - | [1]  19 19 💬
 | 
| 166 | Gene-modified autologous fibroblasts | - | - | - | - | [1]  36 36 💬
 | 
| 167 | Gene-modified autologous stem cells | - | - | - | - | [1]  285 285 💬
 | 
| 168 | Gene-Transduced Autologous CD34+ Stem Cells | - | - | - | - | [1]  65 65 💬
 | 
| 169 | General anesthesia | - | - | - | - | [1]  6 6 💬
 | 
| 170 | General Corticotherapy | - | - | - | - | [1]  35 35 💬
 | 
| 171 | Genetic analyses | - | - | - | - | [1]  19 19 💬
 | 
| 172 | Genetic analysis | - | - | - | - | [6]  34 34, 85, 90, 93, 94, 96 💬
 | 
| 173 | Genetic analysis by SANGER and WHOLE EXOME NEXT GENERATION SEQUENCING | - | - | - | - | [1]  84 84 💬
 | 
| 174 | Genetic characterization | - | - | - | - | [1]  113 113 💬
 | 
| 175 | Genetic diagnosis | - | - | - | - | [1]  335 335 💬
 | 
| 176 | Genetic HMI-203 | - | - | - | - | [1]  19 19 💬
 | 
| 177 | Genetic sequencing | - | - | - | - | [2]  40 40, 231 💬
 | 
| 178 | Genetic test | - | - | - | - | [1]  171 171 💬
 | 
| 179 | Genetic testing | - | - | - | - | [3]  6 6, 90, 299 💬
 | 
| 180 | Genetically corrected cultured epidermal autograft (ATMP) | - | - | - | - | [1]  36 36 💬
 | 
| 181 | Genetically Engineered Hematopoietic Stem Progenitor Cells | - | - | - | - | [1]  285 285 💬
 | 
| 182 | Genetically Engineered Hematopoietic Stem/Progenitor Cells | - | - | - | - | [1]  285 285 💬
 | 
| 183 | Genetically modified autologous blood stem cells | - | - | - | - | [1]  65 65 💬
 | 
| 184 | Genicular nerve block | - | - | - | - | [1]  107 107 💬
 | 
| 185 | GENISTEIN | [1]  Genistein Genistein | [1]  Genistein 
                
                    Genistein
                
             💬
 | - | - | [2]  19 19, 299 💬
 | 
| 186 | Genistein (Unconjugated Isoflavones 100) | [1]  Genistein Genistein | [1]  Genistein 
                
                    Genistein
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 187 | Genistein aglycone | [1]  Genistein Genistein | [1]  Genistein 
                
                    Genistein
                
             💬
 | - | - | [1]  19 19 💬
 | 
| 188 | Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg | - | - | - | - | [1]  299 299 💬
 | 
| 189 | Genome-wide DNA methylation | - | - | - | - | [1]  96 96 💬
 | 
| 190 | Genomic sequencing | - | - | - | - | [1]  58 58 💬
 | 
| 191 | GENOTONORM | - | - | - | - | [1]  193 193 💬
 | 
| 192 | Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 193 | Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 194 | Genotonorm Miniquick 0,2 mg | - | - | - | - | [1]  193 193 💬
 | 
| 195 | Genotropin | [1]  Somatotropin Somatotropin | - | - | - | [5]  13 13, 78, 107, 187, 193 💬
 | 
| 196 | Genotropin (human recombinant Growth hormone) | [1]  Somatotropin Somatotropin | - | - | - | [1]  265 265 💬
 | 
| 197 | Genotropin (PN-180,307) Somatropin | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 198 | GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made. | [1]  Somatotropin Somatotropin | - | - | - | [1]  193 193 💬
 | 
| 199 | Genotropin 12 mg | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 200 | GENOTROPIN 12 mg powder and solvent for solution for injection. | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 201 | Genotropin 12 mg/ml | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 202 | Genotropin 12mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 203 | Genotropin 5 mg/ml | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 204 | Genotropin 5.3 mg in injection system Genotropin pen | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 205 | Genotropin 5.3mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 206 | Genotropin GoQuick | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 207 | Genotropin Mark VII pen | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 208 | Genotropin Miniqu | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 209 | Genotropin MiniQuick | - | - | - | - | [1]  78 78 💬
 | 
| 210 | Genotropin Miniquick 0.2mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 211 | Genotropin Miniquick 0.4mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 212 | Genotropin miniquick 0.5 mg, injection | - | - | - | - | [1]  78 78 💬
 | 
| 213 | Genotropin Miniquick 0.6mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 214 | Genotropin Miniquick 0.8mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 215 | Genotropin Miniquick 1.0mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 216 | Genotropin Miniquick 1.2mg | [1]  Somatotropin Somatotropin | - | - | - | [3]  74 74, 75, 78 💬
 | 
| 217 | GENOTROPIN*1TBF 5,3MG (16UI) | [1]  Somatotropin Somatotropin | - | - | - | [1]  274 274 💬
 | 
| 218 | Genotropin, Genotropin MiniQuick | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 219 | Genotropin/GENOTONORM® | - | - | - | - | [1]  78 78 💬
 | 
| 220 | Genotropin® | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 221 | Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms | - | - | - | - | [1]  11 11 💬
 | 
| 222 | Genotype Detection | - | - | - | - | [1]  49 49 💬
 | 
| 223 | Genoxal | - | - | - | - | [1]  222 222 💬
 | 
| 224 | Gentamicin | [1]  Gentamicin Gentamicin | [1]  Gentamicin 
                
                    Gentamicin
                
             💬
 | - | - | [3]  36 36, 113, 299 💬
 | 
| 225 | Gentamicin infusions twice a week for six months | [1]  Gentamicin Gentamicin | [1]  Gentamicin 
                
                    Gentamicin
                
             💬
 | - | - | [1]  113 113 💬
 | 
| 226 | Gentamicin Sulfate | [2]  Gentamicin Gentamicin, Sulfate ion | [1]  Gentamicin 
                
                    Gentamicin
                
             💬
 | - | - | [1]  36 36 💬
 | 
| 227 | Gentamicin sulfate 0.1% ointment | [2]  Gentamicin Gentamicin, Sulfate ion | [1]  Gentamicin 
                
                    Gentamicin
                
             💬
 | - | - | [1]  36 36 💬
 | 
| 228 | Gentamicin Sulfate, Injectable | [2]  Gentamicin Gentamicin, Sulfate ion | [1]  Gentamicin 
                
                    Gentamicin
                
             💬
 | - | - | [1]  36 36 💬
 | 
| 229 | Genz-112638 | - | - | - | - | [1]  19 19 💬
 | 
| 230 | GENZ-682452 | [1]  Venglustat Venglustat | [1]  Venglustat 
                
                    Venglustat
                
             💬
 | [1]  UGCG UGCG 💬
 | [2]  Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3]  6 6, 19, 67 💬
 | 
| 231 | Genz-682452-AA | [1]  Venglustat Venglustat | [1]  Venglustat 
                
                    Venglustat
                
             💬
 | [1]  UGCG UGCG 💬
 | [2]  Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 232 | Genz-682452-AU | [1]  Venglustat Venglustat | [1]  Venglustat 
                
                    Venglustat
                
             💬
 | [1]  UGCG UGCG 💬
 | [2]  Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | [3]  6 6, 19, 67 💬
 | 
| 233 | Gerilimzumab | - | - | - | - | [1]  46 46 💬
 | 
| 234 | Gernebcin | - | - | - | - | [1]  299 299 💬
 | 
| 235 | Gernebcin 80 mg | - | - | - | - | [1]  299 299 💬
 | 
| 236 | Gevokizumab | [1]  Gevokizumab Gevokizumab | [1]  Gevokizumab 
                
                    Gevokizumab
                
             💬
 | [1]  IL1B IL1B 💬
 | [44]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [4]  41 41, 50, 56, 269 💬
 | 
| 237 | Gevokizumab open-label | [1]  Gevokizumab Gevokizumab | [1]  Gevokizumab 
                
                    Gevokizumab
                
             💬
 | [1]  IL1B IL1B 💬
 | [44]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1]  269 269 💬
 | 
| 238 | GFB-887 | - | - | - | - | [1]  222 222 💬
 | 
| 239 | GFI 38518168-AEK-B-007 | - | - | - | - | [1]  46 46 💬
 | 
| 240 | GFT505 | - | - | - | - | [2]  93 93, 94 💬
 | 
| 241 | GH | - | - | - | - | [1]  3 3 💬
 | 
| 242 | GH substitution | - | - | - | - | [1]  78 78 💬
 | 
| 243 | Ghrelin | [1]  Lenomorelin Lenomorelin | - | - | - | [6]  6 6, 78, 193, 201, 202, 299 💬
 | 
| 244 | GHRH | [1]  Somatorelin Somatorelin | [1]  Somatorelin 
                
                    Somatorelin
                
             💬
 | [1]  GHRHR GHRHR 💬
 | [2]  Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [1]  78 78 💬
 | 
| 245 | GI-270384 | - | - | - | - | [1]  97 97 💬
 | 
| 246 | Gilenya | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3]  2 2, 13, 14 💬
 | 
| 247 | GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  13 13 💬
 | 
| 248 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  13 13 💬
 | 
| 249 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  13 13 💬
 | 
| 250 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  13 13 💬
 | 
| 251 | Gilenya / Imusera | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  13 13 💬
 | 
| 252 | GILENYA 0,5 mg cápsulas duras | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  14 14 💬
 | 
| 253 | Gilenya 0,5 mg Hartkapseln | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  13 13 💬
 | 
| 254 | Gilenya® | [1]  Fingolimod Fingolimod | [1]  Fingolimod 
                
                    Fingolimod
                
             💬
 | [1]  S1PR1 S1PR1 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  13 13 💬
 | 
| 255 | Gileyna | - | - | - | - | [1]  13 13 💬
 | 
| 256 | GILT-rhGAA | - | - | - | - | [1]  256 256 💬
 | 
| 257 | Ginger | [1]  Ginger Ginger | [1]  Ginger 
                
                    Ginger
                
             💬
 | - | - | [2]  46 46, 271 💬
 | 
| 258 | Ginkgo | [1]  Ginkgo biloba Ginkgo biloba | - | - | - | [5]  6 6, 13, 18, 47, 90 💬
 | 
| 259 | Ginkgo biloba | [1]  Ginkgo biloba Ginkgo biloba | - | - | - | [4]  13 13, 18, 47, 90 💬
 | 
| 260 | Ginkgo biloba pills sig: 300mg/tid | [1]  Ginkgo biloba Ginkgo biloba | - | - | - | [1]  90 90 💬
 | 
| 261 | Ginseng | [1]  Ginseng Ginseng | [1]  Ginseng 
                
                    Ginseng
                
             💬
 | - | - | [3]  13 13, 46, 53 💬
 | 
| 262 | Ginsenoside | [1]  Ginsenosides Ginsenosides | - | - | - | [1]  46 46 💬
 | 
| 263 | GIP | - | - | - | - | [1]  299 299 💬
 | 
| 264 | Giving DHA-rich supplement | - | - | - | - | [1]  299 299 💬
 | 
| 265 | Givinostat | [1]  Givinostat Givinostat | - | - | - | [2]  107 107, 113 💬
 | 
| 266 | Givinostat (hydrochloride monohydrate) | [1]  Givinostat Givinostat | - | - | - | [1]  113 113 💬
 | 
| 267 | Givinostat (hydrochloride-monohydrate) | [1]  Givinostat Givinostat | - | - | - | [1]  107 107 💬
 | 
| 268 | GIVINOSTAT (hyrochloride monohydrate) | [1]  Givinostat Givinostat | - | - | - | [1]  113 113 💬
 | 
| 269 | Givinostat (idrocloruro monoidrato) | [1]  Givinostat Givinostat | - | - | - | [1]  113 113 💬
 | 
| 270 | Givosiran | [1]  Givosiran Givosiran | [1]  Givosiran 
                
                    Givosiran
                
             💬
 | [1]  ALAS1 ALAS1 💬
 | [4]  Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | [1]  254 254 💬
 | 
| 271 | Givosiran (ALN-AS1) | [1]  Givosiran Givosiran | [1]  Givosiran 
                
                    Givosiran
                
             💬
 | [1]  ALAS1 ALAS1 💬
 | [4]  Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | [1]  254 254 💬
 | 
| 272 | GKT137831 | - | - | - | - | [2]  85 85, 93 💬
 | 
| 273 | GL701 | - | - | - | - | [1]  49 49 💬
 | 
| 274 | GLA | - | - | - | - | [2]  13 13, 19 💬
 | 
| 275 | GLA gene | - | - | - | - | [1]  19 19 💬
 | 
| 276 | GLA genetic sequencing. | - | - | - | - | [1]  19 19 💬
 | 
| 277 | Glargine | - | - | - | - | [1]  299 299 💬
 | 
| 278 | Glargine insulin | - | - | - | - | [1]  299 299 💬
 | 
| 279 | Glassia | [1]  Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | [1]  231 231 💬
 | 
| 280 | Glatiramer | [1]  Glatiramer Glatiramer | - | - | - | [4]  2 2, 13, 96, 156 💬
 | 
| 281 | GLATIRAMER ACETATE | [2]  Acetate Acetate, Glatiramer | - | - | - | [3]  13 13, 96, 156 💬
 | 
| 282 | Glatiramer Acetate (Copaxone®) | [2]  Acetate Acetate, Glatiramer | - | - | - | [2]  13 13, 156 💬
 | 
| 283 | Glatiramer Acetate (DB) | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 284 | Glatiramer Acetate (GA) | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 285 | Glatiramer Acetate (GA) 40 mg | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 286 | Glatiramer Acetate (GTR) | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 287 | Glatiramer Acetate (OL) | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 288 | Glatiramer acetate 150mg enteric coated tablets | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 289 | Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 290 | Glatiramer acetate 20 mg | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 291 | Glatiramer acetate 20 mg, with mitoxantrone | [3]  Acetate Acetate, Glatiramer, Mitoxantrone | [1]  Mitoxantrone 
                
                    Mitoxantrone
                
             💬
 | [2]  TOP2A TOP2A, TOP2B 💬
 | [1]  Platinum drug resistance Platinum drug resistance 💬 | [1]  13 13 💬
 | 
| 292 | Glatiramer Acetate 20 mg/0.5 mL | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 293 | Glatiramer acetate 40 mg | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 294 | Glatiramer Acetate [GA] | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 295 | Glatiramer acetate injection with oral cetirizine hydrochloride | [3]  Acetate Acetate, Cetirizine, Glatiramer | [1]  Cetirizine 
                
                    Cetirizine
                
             💬
 | [1]  HRH1 HRH1 💬
 | [3]  Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1]  13 13 💬
 | 
| 296 | Glatiramer acetate with minocycline | [3]  Acetate Acetate, Glatiramer, Minocycline | [1]  Minocycline 
                
                    Minocycline
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 297 | Glatiramer acetate, (Copaxone®) | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 298 | Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b | [2]  Acetate Acetate, Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 299 | Glatiramer Acetate, N-Acetylcysteine | [3]  Acetate Acetate, Acetylcysteine, Glatiramer | [1]  Acetylcysteine 
                
                    Acetylcysteine
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 300 | GLATIRAMER ACETATO | [1]  Glatiramer Glatiramer | - | - | - | [1]  13 13 💬
 | 
| 301 | GLATIRAMERO ACETATO | - | - | - | - | [1]  13 13 💬
 | 
| 302 | Gleevec | - | - | - | - | [1]  34 34 💬
 | 
| 303 | Glentek 50 mg compresse rivestite con film | - | - | - | - | [1]  18 18 💬
 | 
| 304 | Glentek 50 mg film-coated tablets | - | - | - | - | [1]  18 18 💬
 | 
| 305 | Glial cell line-derived neurotrophic factor | - | - | - | - | [1]  6 6 💬
 | 
| 306 | Glial Cell Line-Derived Neurotrophic Factor (GDNF) | - | - | - | - | [1]  6 6 💬
 | 
| 307 | Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato | - | - | - | - | [1]  13 13 💬
 | 
| 308 | Gliolan | [1]  Aminolevulinic acid Aminolevulinic acid | [1]  Aminolevulinic acid 
                
                    Aminolevulinic acid
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 309 | GLIVEC | [1]  Imatinib Imatinib | [1]  Imatinib 
                
                    Imatinib
                
             💬
 | [3]  ABL1 ABL1, KIT, PDGFRA 💬
 | [32]  Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [2]  51 51, 86 💬
 | 
| 310 | GLIVEC 100 mg comprimidos recubiertos con película | [1]  Imatinib Imatinib | [1]  Imatinib 
                
                    Imatinib
                
             💬
 | [3]  ABL1 ABL1, KIT, PDGFRA 💬
 | [32]  Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [2]  34 34, 86 💬
 | 
| 311 | Glivec 100 mg Filmtabletten | [1]  Imatinib Imatinib | [1]  Imatinib 
                
                    Imatinib
                
             💬
 | [3]  ABL1 ABL1, KIT, PDGFRA 💬
 | [32]  Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [2]  51 51, 86 💬
 | 
| 312 | Glivec 100 mg Hartkapsel | [1]  Imatinib Imatinib | [1]  Imatinib 
                
                    Imatinib
                
             💬
 | [3]  ABL1 ABL1, KIT, PDGFRA 💬
 | [32]  Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1]  86 86 💬
 | 
| 313 | GLIVEC 400 mg comprimidos recubiertos con película | [1]  Imatinib Imatinib | [1]  Imatinib 
                
                    Imatinib
                
             💬
 | [3]  ABL1 ABL1, KIT, PDGFRA 💬
 | [32]  Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1]  34 34 💬
 | 
| 314 | Glivec® | [1]  Imatinib Imatinib | [1]  Imatinib 
                
                    Imatinib
                
             💬
 | [3]  ABL1 ABL1, KIT, PDGFRA 💬
 | [32]  Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1]  86 86 💬
 | 
| 315 | Glivec® 100 mg Filmtabletten | [1]  Imatinib Imatinib | [1]  Imatinib 
                
                    Imatinib
                
             💬
 | [3]  ABL1 ABL1, KIT, PDGFRA 💬
 | [32]  Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1]  86 86 💬
 | 
| 316 | Global DNA methylation will be quantified in the DNA samples by colorimetry | - | - | - | - | [1]  63 63 💬
 | 
| 317 | GLP-1 | - | - | - | - | [1]  299 299 💬
 | 
| 318 | GLPG0259 | - | - | - | - | [1]  46 46 💬
 | 
| 319 | GLPG0259 (Part B) | - | - | - | - | [1]  46 46 💬
 | 
| 320 | GLPG0259 oral capsule | - | - | - | - | [1]  46 46 💬
 | 
| 321 | GLPG0634 | - | - | - | - | [3]  46 46, 96, 271 💬
 | 
| 322 | GLPG0974 | - | - | - | - | [1]  97 97 💬
 | 
| 323 | GLPG1205 | - | - | - | - | [3]  85 85, 96, 97 💬
 | 
| 324 | GLPG1690 | - | - | - | - | [2]  51 51, 85 💬
 | 
| 325 | GLPG1690 600 mg QD | - | - | - | - | [1]  85 85 💬
 | 
| 326 | GLPG1837 | - | - | - | - | [1]  299 299 💬
 | 
| 327 | GLPG1837 dose 1 | - | - | - | - | [1]  299 299 💬
 | 
| 328 | GLPG1837 dose 2 | - | - | - | - | [1]  299 299 💬
 | 
| 329 | GLPG1837 dose 3 | - | - | - | - | [1]  299 299 💬
 | 
| 330 | GLPG2222 | - | - | - | - | [1]  299 299 💬
 | 
| 331 | GLPG2222 100 mg | - | - | - | - | [1]  299 299 💬
 | 
| 332 | GLPG2222 150 mg q.d. | - | - | - | - | [1]  299 299 💬
 | 
| 333 | GLPG2222 200 mg | - | - | - | - | [1]  299 299 💬
 | 
| 334 | GLPG2222 300 mg q.d. | - | - | - | - | [1]  299 299 💬
 | 
| 335 | GLPG2222 400 mg | - | - | - | - | [1]  299 299 💬
 | 
| 336 | GLPG2222 50 mg | - | - | - | - | [1]  299 299 💬
 | 
| 337 | GLPG2451 dose regimen A | - | - | - | - | [1]  299 299 💬
 | 
| 338 | GLPG2451 dose regimen B | - | - | - | - | [1]  299 299 💬
 | 
| 339 | GLPG2737 | - | - | - | - | [2]  67 67, 299 💬
 | 
| 340 | GLPG2737 single dose | - | - | - | - | [1]  299 299 💬
 | 
| 341 | GLPG3067 | - | - | - | - | [1]  299 299 💬
 | 
| 342 | GLPG3067 single dose | - | - | - | - | [1]  299 299 💬
 | 
| 343 | GLPG3667 | - | - | - | - | [1]  50 50 💬
 | 
| 344 | GLPG3970 | - | - | - | - | [3]  46 46, 53, 97 💬
 | 
| 345 | GLPG3970 film-coated tablet | - | - | - | - | [1]  49 49 💬
 | 
| 346 | GLUCOCEREBROSIDASE | - | - | - | - | [1]  19 19 💬
 | 
| 347 | GLUCOCEREBROSIDASE UMANO GENE-ATTIVATO | - | - | - | - | [1]  19 19 💬
 | 
| 348 | GlucoCorticoid | - | - | - | - | [2]  46 46, 228 💬
 | 
| 349 | Glucocorticoid (GC) | - | - | - | - | [2]  43 43, 44 💬
 | 
| 350 | Glucocorticoid (prednisone or prednisolone) | [2]  Prednisolone Prednisolone, Prednisone | [2]  Prednisolone 
                
                    Prednisolone
                
            , 
                
                    Prednisone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  84 84 💬
 | 
| 351 | Glucocorticoid + cytoxan | - | - | - | - | [1]  222 222 💬
 | 
| 352 | Glucocorticoid + tacrolimus | [1]  Tacrolimus Tacrolimus | [2]  Tacrolimus 
                
                    Tacrolimus
                
            , 
                
                    Tacrolimus
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  222 222 💬
 | 
| 353 | Glucocorticoid Agent | - | - | - | - | [1]  46 46 💬
 | 
| 354 | Glucocorticoid combined with cyclophosphamide induction + maintenance | [1]  Cyclophosphamide Cyclophosphamide | [2]  Cyclophosphamide 
                
                    Cyclophosphamide
                
            , 
                
                    Cyclophosphamide
                
             💬
 | - | - | [1]  222 222 💬
 | 
| 355 | Glucocorticoid Treatment | - | - | - | - | [1]  41 41 💬
 | 
| 356 | Glucocorticoids | - | - | - | - | [8]  40 40, 41, 43, 44, 60, 62, 75, 300 💬
 | 
| 357 | Glucocorticoids (GC) | - | - | - | - | [2]  43 43, 44 💬
 | 
| 358 | Glucocorticoids (permitted,not necessary) | - | - | - | - | [1]  46 46 💬
 | 
| 359 | Glucocorticoids - Reduced Dose | - | - | - | - | [2]  43 43, 44 💬
 | 
| 360 | Glucocorticoids - Standard Dose | - | - | - | - | [2]  43 43, 44 💬
 | 
| 361 | Glucocorticoids [Reduced Dose] | - | - | - | - | [2]  43 43, 44 💬
 | 
| 362 | Glucocorticoids [Standard Dose] | - | - | - | - | [2]  43 43, 44 💬
 | 
| 363 | Glucophage (metformin) | [1]  Metformin Metformin | [1]  Metformin 
                
                    Metformin
                
             💬
 | [2]  PRKAA1 PRKAA1, PRKAA2 💬
 | [20]  AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [2]  46 46, 75 💬
 | 
| 364 | Glucorticoid Taper Regimen | - | - | - | - | [1]  40 40 💬
 | 
| 365 | Glucose | [2]  D-glucose D-glucose, Dextrose, unspecified form | [1]  Glucose 
                
                    Glucose
                
             💬
 | - | - | [12]  2 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬
 | 
| 366 | Glucose intake | [1]  Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1]  257 257 💬
 | 
| 367 | Glucose Tablet | [1]  Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1]  50 50 💬
 | 
| 368 | Glucosidase alfa | - | - | - | - | [1]  256 256 💬
 | 
| 369 | GLUT1 DS | - | - | - | - | [1]  248 248 💬
 | 
| 370 | Glutamate and aspartate | - | - | - | - | [1]  13 13 💬
 | 
| 371 | Glutamine | [1]  L-Glutamine L-Glutamine | [1]  Glutamine 
                
                    Glutamine
                
             💬
 | - | - | [8]  87 87, 89, 96, 97, 113, 222, 245, 299 💬
 | 
| 372 | Glutathione | [1]  Glutathione Glutathione | [2]  Glutathione 
                
                    Glutathione
                
            , 
                
                    Oxiglutatione
                
             💬
 | - | - | [2]  6 6, 299 💬
 | 
| 373 | GLUTATHIONE SODIUM | [1]  Glutathione Glutathione | [2]  Glutathione 
                
                    Glutathione
                
            , 
                
                    Oxiglutatione
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 374 | Gluten-free diet | - | - | - | - | [1]  94 94 💬
 | 
| 375 | GLWL-01 | - | - | - | - | [1]  193 193 💬
 | 
| 376 | Glycerol | [1]  Glycerin Glycerin | [1]  Glycerin 
                
                    Glycerin
                
             💬
 | - | - | [5]  6 6, 13, 79, 316, 317 💬
 | 
| 377 | Glycerol Phenylbutyrate | [3]  Glycerin Glycerin, Glycerol phenylbutyrate, Phenylbutyric acid | [2]  Glycerin 
                
                    Glycerin
                
            , 
                
                    Glycerol phenylbutyrate
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 378 | Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate | [1]  Glycerin Glycerin | [1]  Glycerin 
                
                    Glycerin
                
             💬
 | - | - | [1]  13 13 💬
 | 
| 379 | Glycerol/Saline | [1]  Glycerin Glycerin | [1]  Glycerin 
                
                    Glycerin
                
             💬
 | - | - | [2]  316 316, 317 💬
 | 
| 380 | Glyceryl tri-(4-phenylbutyrate) | [1]  Phenylbutyric acid Phenylbutyric acid | - | - | - | [1]  251 251 💬
 | 
| 381 | Glyceryl tri-(4-phenylbutyrate)(GT4P) | [2]  Glycerol phenylbutyrate Glycerol phenylbutyrate, Phenylbutyric acid | [1]  Glycerol phenylbutyrate 
                
                    Glycerol phenylbutyrate
                
             💬
 | - | - | [1]  251 251 💬
 | 
| 382 | Glyceryl triacetate | [1]  Triacetin Triacetin | [1]  Triacetin 
                
                    Triacetin
                
             💬
 | - | - | [1]  307 307 💬
 | 
| 383 | Glyceryl Trierucate | [1]  Glyceryl Trierucate Glyceryl Trierucate | - | - | - | [1]  20 20 💬
 | 
| 384 | Glyceryl trierucate/glyceryl trioleate | [2]  Glyceryl Trierucate Glyceryl Trierucate, Glyceryl Trioleate | - | - | - | [1]  20 20 💬
 | 
| 385 | Glyceryl Trioleate | [1]  Glyceryl Trioleate Glyceryl Trioleate | - | - | - | [1]  20 20 💬
 | 
| 386 | GLYCINE | [1]  Glycine Glycine | [1]  Glycine 
                
                    Glycine
                
             💬
 | - | - | [5]  35 35, 60, 86, 226, 299 💬
 | 
| 387 | Glycine Buffer | [1]  Glycine Glycine | [1]  Glycine 
                
                    Glycine
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 388 | Glycolic acid | [1]  Glycolic acid Glycolic acid | - | - | - | [1]  65 65 💬
 | 
| 389 | Glycomacropeptide-based protein substitute | - | - | - | - | [1]  240 240 💬
 | 
| 390 | Glycopyrrolate | - | - | - | - | [2]  6 6, 34 💬
 | 
| 391 | Glycosade | - | - | - | - | [3]  65 65, 256, 257 💬
 | 
| 392 | GlycosBio Nutritional Supplement | - | - | - | - | [1]  299 299 💬
 | 
| 393 | Glycosides Of Tripterygium Wilfordii Hook(GTW) | [1]  Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [1]  224 224 💬
 | 
| 394 | Glycyrrhetinic Acid | - | - | - | - | [1]  63 63 💬
 | 
| 395 | Glycyrrhiza | [1]  Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [2]  53 53, 97 💬
 | 
| 396 | Glycyrrhiza glabra | [1]  Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [1]  97 97 💬
 | 
| 397 | GLYCYRRHIZA GLABRA ROOT | [1]  Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | [1]  97 97 💬
 | 
| 398 | Glycyrrhizin | [1]  Glycyrrhizic acid Glycyrrhizic acid | [1]  Glycyrrhizin 
                
                    Glycyrrhizin
                
             💬
 | - | - | [2]  46 46, 51 💬
 | 
| 399 | GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.) | - | - | - | - | [1]  299 299 💬
 | 
| 400 | GM-CSF | - | - | - | - | [3]  51 51, 60, 229 💬
 | 
| 401 | GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim) | [1]  Sargramostim Sargramostim | [1]  Sargramostim 
                
                    Sargramostim
                
             💬
 | [1]  CSF2RA CSF2RA 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1]  229 229 💬
 | 
| 402 | GM-CSF [Leukine (Sargramostim)] | [1]  Sargramostim Sargramostim | [1]  Sargramostim 
                
                    Sargramostim
                
             💬
 | [1]  CSF2RA CSF2RA 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1]  229 229 💬
 | 
| 403 | GM-CSF inhalation therapy | - | - | - | - | [1]  229 229 💬
 | 
| 404 | GM-CSF, fosfomycin and metronidazole | [2]  Fosfomycin Fosfomycin, Metronidazole | [2]  Metronidazole 
                
                    Metronidazole
                
            , 
                
                    Fosfomycin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 405 | GM1 ganglioside | - | - | - | - | [1]  6 6 💬
 | 
| 406 | GM604 | [1]  Alirinetide Alirinetide | - | - | - | [1]  2 2 💬
 | 
| 407 | GM608 | [1]  Alirinetide Alirinetide | - | - | - | [1]  6 6 💬
 | 
| 408 | GMA161 | - | - | - | - | [1]  63 63 💬
 | 
| 409 | GMA301 Injection | - | - | - | - | [1]  86 86 💬
 | 
| 410 | GNbAC1 | - | - | - | - | [1]  13 13 💬
 | 
| 411 | GNbAC1 Monoclonal Antibody | - | - | - | - | [1]  13 13 💬
 | 
| 412 | GNR-055 | - | - | - | - | [1]  19 19 💬
 | 
| 413 | GNR-055 1.0-2.0-3.0 mg/kg | - | - | - | - | [1]  19 19 💬
 | 
| 414 | GNR-055 2.0 mg/kg | - | - | - | - | [1]  19 19 💬
 | 
| 415 | GNR-055 3.0 mg/kg | - | - | - | - | [1]  19 19 💬
 | 
| 416 | GNR-069 | - | - | - | - | [1]  63 63 💬
 | 
| 417 | GnRH | [1]  Gonadorelin Gonadorelin | [1]  Gonadorelin 
                
                    Gonadorelin
                
             💬
 | [1]  GNRHR GNRHR 💬
 | [2]  GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1]  76 76 💬
 | 
| 418 | GnRH agonist | [1]  Gonadorelin Gonadorelin | [1]  Gonadorelin 
                
                    Gonadorelin
                
             💬
 | [1]  GNRHR GNRHR 💬
 | [2]  GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1]  76 76 💬
 | 
| 419 | GNT0004 | - | - | - | - | [1]  113 113 💬
 | 
| 420 | GNT0006 | - | - | - | - | [1]  113 113 💬
 | 
| 421 | GOCOVRI | - | - | - | - | [1]  6 6 💬
 | 
| 422 | GOL | - | - | - | - | [1]  46 46 💬
 | 
| 423 | Gold | [1]  Gold Gold | - | - | - | [43]  2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬
 | 
| 424 | Gold Nanocrystals | [1]  Gold Gold | - | - | - | [3]  2 2, 6, 13 💬
 | 
| 425 | GOLEXANOLONE | - | - | - | - | [1]  93 93 💬
 | 
| 426 | GOLIMUMAB | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8]  46 46, 56, 84, 96, 97, 107, 270, 271 💬
 | 
| 427 | Golimumab (CNTO 148) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  271 271 💬
 | 
| 428 | Golimumab (GLM) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 429 | Golimumab (GOL) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  56 56 💬
 | 
| 430 | Golimumab (Optimization) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 431 | Golimumab 1 mg per kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 432 | Golimumab 100 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 97 💬
 | 
| 433 | Golimumab 100 mg injections | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 434 | Golimumab 2 mg per kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 435 | Golimumab 2 mg/kg IV | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 436 | Golimumab 200 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 437 | Golimumab 4 mg per kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 438 | Golimumab 400 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 439 | Golimumab 50 mg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 97 💬
 | 
| 440 | Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 441 | Golimumab 50 mg injections | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 442 | Golimumab 50 mg SC | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 443 | Golimumab Dose 1 | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 444 | Golimumab Dose 2 | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 445 | Golimumab Final Vialed Product (FVP) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 446 | Golimumab Injection | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  271 271 💬
 | 
| 447 | Golimumab Intravenous | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 448 | Golimumab Intravenous (IV) | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 449 | Golimumab liquid in prefilled pen | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 450 | Golimumab liquid in prefilled pen or Prefilled Syringe | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 451 | Golimumab Liquid in prefilled syringe | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 84, 97, 107 💬
 | 
| 452 | Golimumab Liquid in Vial | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 97, 271 💬
 | 
| 453 | Golimumab Pre-Filled Syringe | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 271 💬
 | 
| 454 | Golimumab prefilled pen | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 455 | Golimumab prefilled pen or prefilled syringe | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 456 | Golimumab Prefilled Syringe | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 457 | Golimumab treatment optimization. | [1]  Golimumab Golimumab | [1]  Golimumab 
                
                    Golimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 458 | GOLODIRSEN | [1]  Golodirsen Golodirsen | [1]  Golodirsen 
                
                    Golodirsen
                
             💬
 | [1]  DMD DMD 💬
 | [4]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1]  113 113 💬
 | 
| 459 | Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53] | [1]  Golodirsen Golodirsen | [1]  Golodirsen 
                
                    Golodirsen
                
             💬
 | [1]  DMD DMD 💬
 | [4]  Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1]  113 113 💬
 | 
| 460 | Goserelin | [1]  Goserelin Goserelin | [1]  Goserelin 
                
                    Goserelin
                
             💬
 | [1]  GNRHR GNRHR 💬
 | [2]  GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1]  1 1 💬
 | 
| 461 | GP2013 | - | - | - | - | [1]  46 46 💬
 | 
| 462 | GP2013 - A Proposed biosimilar rituximab | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 463 | GP2015 | - | - | - | - | [1]  46 46 💬
 | 
| 464 | GP2017 | - | - | - | - | [2]  46 46, 271 💬
 | 
| 465 | GP2017 (adalimumab biosimilar) | [1]  Adalimumab Adalimumab | [1]  Adalimumab 
                
                    Adalimumab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  271 271 💬
 | 
| 466 | Gp91 Grans | - | - | - | - | [1]  65 65 💬
 | 
| 467 | GPI 1485 | - | - | - | - | [1]  6 6 💬
 | 
| 468 | GR181413 | - | - | - | - | [1]  19 19 💬
 | 
| 469 | GR181413A | - | - | - | - | [1]  19 19 💬
 | 
| 470 | GR181413A/AT1001 capsule | - | - | - | - | [1]  19 19 💬
 | 
| 471 | GR181413A/AT1001 solution | - | - | - | - | [1]  19 19 💬
 | 
| 472 | GR3027 | - | - | - | - | [1]  93 93 💬
 | 
| 473 | Gradient | - | - | - | - | [1]  149 149 💬
 | 
| 474 | Graft intracerebral of foetal neurons | - | - | - | - | [1]  8 8 💬
 | 
| 475 | Graft-versus-tumor induction therapy | - | - | - | - | [2]  60 60, 285 💬
 | 
| 476 | Gralise | - | - | - | - | [2]  97 97, 226 💬
 | 
| 477 | Gran | - | - | - | - | [1]  51 51 💬
 | 
| 478 | Granocyte | - | - | - | - | [2]  18 18, 57 💬
 | 
| 479 | GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF) | [1]  Lenograstim Lenograstim | [1]  Lenograstim 
                
                    Lenograstim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1]  57 57 💬
 | 
| 480 | Granocyte Lenograstim | [1]  Lenograstim Lenograstim | [1]  Lenograstim 
                
                    Lenograstim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1]  57 57 💬
 | 
| 481 | Granulated mesalamine | [1]  Mesalazine Mesalazine | [1]  Mesalamine 
                
                    Mesalamine
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 482 | Granulocyte - colony stimulating factor (G-CSF) | [1]  Filgrastim Filgrastim | [1]  Filgrastim 
                
                    Filgrastim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1]  2 2 💬
 | 
| 483 | Granulocyte Colony Stimulating Factor | [1]  Filgrastim Filgrastim | [1]  Filgrastim 
                
                    Filgrastim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [6]  2 2, 28, 36, 57, 65, 85 💬
 | 
| 484 | Granulocyte colony stimulating factor (G-CSF) | [1]  Filgrastim Filgrastim | [1]  Filgrastim 
                
                    Filgrastim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1]  65 65 💬
 | 
| 485 | Granulocyte Colony Stimulating Factor (GCSF) | [1]  Filgrastim Filgrastim | [1]  Filgrastim 
                
                    Filgrastim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [2]  36 36, 57 💬
 | 
| 486 | Granulocyte Colony-Stimulating Factor | - | - | - | - | [1]  296 296 💬
 | 
| 487 | Granulocyte colony-stimulating factor (Filgrastim) | [1]  Filgrastim Filgrastim | [1]  Filgrastim 
                
                    Filgrastim
                
             💬
 | [1]  CSF3R CSF3R 💬
 | [5]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1]  113 113 💬
 | 
| 488 | Granulocyte-colony stimulating factor (G-CSF) and prednisone | [2]  Filgrastim Filgrastim, Prednisone | [2]  Prednisone 
                
                    Prednisone
                
            , 
                
                    Filgrastim
                
             💬
 | [2]  CSF3R CSF3R, NR3C1 💬
 | [6]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1]  13 13 💬
 | 
| 489 | Granulocyte-macrophage colony stimulating factor (GM-CSF) | - | - | - | - | [1]  229 229 💬
 | 
| 490 | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) | - | - | - | - | [1]  11 11 💬
 | 
| 491 | Grapefruit | [1]  Grapefruit Grapefruit | - | - | - | [5]  6 6, 46, 50, 83, 97 💬
 | 
| 492 | Grapefruit Juice | [1]  Grapefruit Grapefruit | - | - | - | [1]  83 83 💬
 | 
| 493 | GRC 4039 | - | - | - | - | [1]  46 46 💬
 | 
| 494 | Green Tea | [1]  Green tea leaf Green tea leaf | [1]  Green tea leaf 
                
                    Green tea leaf
                
             💬
 | - | - | [4]  6 6, 17, 28, 46 💬
 | 
| 495 | Green Tea Extract | [1]  Green tea leaf Green tea leaf | [1]  Green tea leaf 
                
                    Green tea leaf
                
             💬
 | - | - | [1]  28 28 💬
 | 
| 496 | Green tea group | [1]  Green tea leaf Green tea leaf | [1]  Green tea leaf 
                
                    Green tea leaf
                
             💬
 | - | - | [1]  46 46 💬
 | 
| 497 | GREEN TEA LEAF | [2]  Green tea leaf Green tea leaf, Tea leaf | [1]  Green tea leaf 
                
                    Green tea leaf
                
             💬
 | - | - | [1]  17 17 💬
 | 
| 498 | Green Tea Polyphenols (EGCG/ECG) | [2]  Epigallocatechin gallate Epigallocatechin gallate, Green tea leaf | [1]  Green tea leaf 
                
                    Green tea leaf
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 499 | GRF6021 | - | - | - | - | [1]  6 6 💬
 | 
| 500 | Group 1 or Orencia treated group | [1]  Abatacept Abatacept | [1]  Abatacept 
                
                    Abatacept
                
             💬
 | [2]  CD80 CD80, CD86 💬
 | [13]  Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [1]  46 46 💬
 | 
| 501 | Group 1- Control Diet | - | - | - | - | [1]  97 97 💬
 | 
| 502 | Group 2 ustekinumab 130 mg | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1]  96 96 💬
 | 
| 503 | Group 2- UCD Diet | - | - | - | - | [1]  97 97 💬
 | 
| 504 | Group 3: ustekinumab approximately 6 mg/kg | [1]  Ustekinumab Ustekinumab | [1]  Ustekinumab 
                
                    Ustekinumab
                
             💬
 | [3]  IL12A IL12A, IL12B, IL23A 💬
 | [28]  African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1]  96 96 💬
 | 
| 505 | Group AD Anti-PD + Antidepressant | - | - | - | - | [1]  6 6 💬
 | 
| 506 | Group C meningococcal conjugate vaccine | - | - | - | - | [1]  14 14 💬
 | 
| 507 | Group R Rasagiline | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 508 | Group R+AD Rasagiline + Antidepressant | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 509 | Growth hormone | [1]  Somatotropin Somatotropin | - | - | - | [14]  2 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299 💬
 | 
| 510 | Growth hormone (Genotonorm® or Omnitrope®) | [1]  Somatotropin Somatotropin | - | - | - | [2]  78 78, 193 💬
 | 
| 511 | Growth hormone (Genotropin) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 512 | Growth hormone (Nutropin) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 513 | Growth Hormone (Somatropin) | [1]  Somatotropin Somatotropin | - | - | - | [2]  2 2, 78 💬
 | 
| 514 | Growth hormone - LB03002 | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 515 | Growth hormone administration for 6 months | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 516 | Growth Hormone Releasing Hormone | [1]  Somatotropin Somatotropin | - | - | - | [1]  265 265 💬
 | 
| 517 | Growth hormone releasing hormone (GHRH) 1-44 | [2]  Somatorelin Somatorelin, Somatotropin | [1]  Somatorelin 
                
                    Somatorelin
                
             💬
 | [1]  GHRHR GHRHR 💬
 | [2]  Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [1]  78 78 💬
 | 
| 518 | Growth hormone releasing hormone (GHRH) and arginine | [3]  Arginine Arginine, Somatorelin, Somatotropin | [2]  Arginine 
                
                    Arginine
                
            , 
                
                    Somatorelin
                
             💬
 | [1]  GHRHR GHRHR 💬
 | [2]  Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [1]  78 78 💬
 | 
| 519 | Growth Hormone Replacement Therapy | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 520 | Growth hormone replacement therapy in growth hormone deficient patients only. | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 521 | Growth Hormone, GH | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 522 | Growth Hormone-Releasing Hormone | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 523 | GS-248 | - | - | - | - | [1]  51 51 💬
 | 
| 524 | GS-4059 | - | - | - | - | [1]  53 53 💬
 | 
| 525 | GS-4875 | - | - | - | - | [1]  97 97 💬
 | 
| 526 | GS-4997 18 mg | - | - | - | - | [1]  86 86 💬
 | 
| 527 | GS-4997 2 mg | - | - | - | - | [1]  86 86 💬
 | 
| 528 | GS-4997 6 mg | - | - | - | - | [1]  86 86 💬
 | 
| 529 | GS-5718 | - | - | - | - | [1]  46 46 💬
 | 
| 530 | GS-5737 | - | - | - | - | [1]  299 299 💬
 | 
| 531 | GS-5745 | [1]  GS-5745 GS-5745 | - | - | - | [4]  46 46, 96, 97, 299 💬
 | 
| 532 | GS-5745 IV | [1]  GS-5745 GS-5745 | - | - | - | [1]  97 97 💬
 | 
| 533 | GS-5745 SC | [1]  GS-5745 GS-5745 | - | - | - | [1]  97 97 💬
 | 
| 534 | GS-6034 | - | - | - | - | [4]  46 46, 53, 96, 97 💬
 | 
| 535 | GS-6615 3 mg | - | - | - | - | [1]  58 58 💬
 | 
| 536 | GS-6615 3 mg Pink | - | - | - | - | [1]  58 58 💬
 | 
| 537 | GS-6615 3 mg White | - | - | - | - | [1]  58 58 💬
 | 
| 538 | GS-6615 6 mg | - | - | - | - | [1]  58 58 💬
 | 
| 539 | GS-6615 6 mg White | - | - | - | - | [1]  58 58 💬
 | 
| 540 | GS-6624 | [1]  Simtuzumab Simtuzumab | - | - | - | [2]  85 85, 94 💬
 | 
| 541 | GS-9411 | - | - | - | - | [1]  299 299 💬
 | 
| 542 | GS-9674 | - | - | - | - | [2]  93 93, 94 💬
 | 
| 543 | GS-9674 100 mg | - | - | - | - | [1]  93 93 💬
 | 
| 544 | GS-9674 30 mg | - | - | - | - | [1]  93 93 💬
 | 
| 545 | GS-9876 | - | - | - | - | [2]  46 46, 53 💬
 | 
| 546 | GS010 | - | - | - | - | [1]  302 302 💬
 | 
| 547 | GS030-DP | - | - | - | - | [1]  90 90 💬
 | 
| 548 | GSH | - | - | - | - | [2]  6 6, 299 💬
 | 
| 549 | GSH (Glutathione) | [1]  Glutathione Glutathione | [2]  Glutathione 
                
                    Glutathione
                
            , 
                
                    Oxiglutatione
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 550 | GSK 3196165 | - | - | - | - | [1]  46 46 💬
 | 
| 551 | GSK1070806 | - | - | - | - | [2]  56 56, 96 💬
 | 
| 552 | GSK1223249 | - | - | - | - | [2]  2 2, 13 💬
 | 
| 553 | GSK1265744B (sodium salt) containing 14C-GSK1265744B | - | - | - | - | [1]  265 265 💬
 | 
| 554 | GSK1325760 | - | - | - | - | [2]  86 86, 88 💬
 | 
| 555 | GSK1325760A | - | - | - | - | [1]  86 86 💬
 | 
| 556 | GSK1399686 | - | - | - | - | [1]  97 97 💬
 | 
| 557 | GSK1550188 | - | - | - | - | [4]  11 11, 49, 66, 222 💬
 | 
| 558 | GSK1550188 (Belimumab) | [1]  Belimumab Belimumab | [1]  Belimumab 
                
                    Belimumab
                
             💬
 | [1]  TNFSF13B TNFSF13B 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1]  222 222 💬
 | 
| 559 | GSK1550188 1mg/kg or 10mg/kg | - | - | - | - | [1]  49 49 💬
 | 
| 560 | GSK1550188 IV | - | - | - | - | [1]  49 49 💬
 | 
| 561 | GSK1550188 SC | - | - | - | - | [1]  49 49 💬
 | 
| 562 | GSK1605786 | - | - | - | - | [2]  96 96, 97 💬
 | 
| 563 | GSK1605786 500 mg | - | - | - | - | [1]  96 96 💬
 | 
| 564 | GSK1605786 capsule | - | - | - | - | [1]  96 96 💬
 | 
| 565 | GSK1605786 ChemoCentryx: formulation A | - | - | - | - | [1]  96 96 💬
 | 
| 566 | GSK1605786 GSK direct-fill: formulation C | - | - | - | - | [1]  96 96 💬
 | 
| 567 | GSK1605786 GSK modified-process: formulation D | - | - | - | - | [1]  96 96 💬
 | 
| 568 | GSK1605786 GSK tablet: formulation E | - | - | - | - | [1]  96 96 💬
 | 
| 569 | GSK1605786 GSK: formulation B | - | - | - | - | [1]  96 96 💬
 | 
| 570 | GSK1605786A | - | - | - | - | [2]  96 96, 97 💬
 | 
| 571 | GSK1827771 | - | - | - | - | [1]  46 46 💬
 | 
| 572 | GSK1841157 | - | - | - | - | [3]  13 13, 35, 46 💬
 | 
| 573 | GSK2018682 | - | - | - | - | [1]  13 13 💬
 | 
| 574 | GSK2018682 CD2 Capsule | - | - | - | - | [1]  13 13 💬
 | 
| 575 | GSK2018682 CD3 micronised Tablet | - | - | - | - | [1]  13 13 💬
 | 
| 576 | GSK2018682 CD3 non-micronised Tablet | - | - | - | - | [1]  13 13 💬
 | 
| 577 | GSK2018682 CD3 non-micronised Tablet in fed state | - | - | - | - | [1]  13 13 💬
 | 
| 578 | GSK2126458 | - | - | - | - | [1]  85 85 💬
 | 
| 579 | GSK2256098 | [1]  GSK2256098 GSK2256098 | - | - | - | [1]  86 86 💬
 | 
| 580 | GSK2315698 | - | - | - | - | [1]  28 28 💬
 | 
| 581 | GSK2330672 | - | - | - | - | [1]  93 93 💬
 | 
| 582 | GSK2330672/linerixibat 40 mg | - | - | - | - | [1]  93 93 💬
 | 
| 583 | GSK2330811 | - | - | - | - | [2]  51 51, 96 💬
 | 
| 584 | GSK2330811 Solution for Injection, 100mg/ml | - | - | - | - | [1]  51 51 💬
 | 
| 585 | GSK239512 | - | - | - | - | [1]  13 13 💬
 | 
| 586 | GSK2395612 | - | - | - | - | [1]  13 13 💬
 | 
| 587 | GSK2398852 | - | - | - | - | [1]  28 28 💬
 | 
| 588 | GSK2402968 | - | - | - | - | [1]  113 113 💬
 | 
| 589 | GSK2402968 3mg/kg/week | - | - | - | - | [1]  113 113 💬
 | 
| 590 | GSK2402968 6 mg/kg/week | - | - | - | - | [1]  113 113 💬
 | 
| 591 | GSK2402968 6mg/kg/week | - | - | - | - | [1]  113 113 💬
 | 
| 592 | GSK2586184 | - | - | - | - | [1]  49 49 💬
 | 
| 593 | GSK2586184 100 mg | - | - | - | - | [1]  49 49 💬
 | 
| 594 | GSK2586184 200 mg | - | - | - | - | [1]  49 49 💬
 | 
| 595 | GSK2586184 400 mg | - | - | - | - | [1]  49 49 💬
 | 
| 596 | GSK2586184 400mg | - | - | - | - | [1]  97 97 💬
 | 
| 597 | GSK2586184 50 mg | - | - | - | - | [1]  49 49 💬
 | 
| 598 | GSK2586184 800mg single and repeat dose | - | - | - | - | [1]  49 49 💬
 | 
| 599 | GSK2586184 new formulation | - | - | - | - | [1]  49 49 💬
 | 
| 600 | GSK2586184 standard formulation | - | - | - | - | [1]  49 49 💬
 | 
| 601 | GSK2586881 | - | - | - | - | [1]  86 86 💬
 | 
| 602 | GSK2618960 | - | - | - | - | [1]  53 53 💬
 | 
| 603 | GSK2618960 2 mg/kg | - | - | - | - | [1]  53 53 💬
 | 
| 604 | GSK2788723 | - | - | - | - | [1]  19 19 💬
 | 
| 605 | GSK2831781 | - | - | - | - | [1]  97 97 💬
 | 
| 606 | GSK2831781 - Double Blind Phase | - | - | - | - | [1]  97 97 💬
 | 
| 607 | GSK2831781 - Open Label phase | - | - | - | - | [1]  97 97 💬
 | 
| 608 | GSK2857916 | - | - | - | - | [1]  28 28 💬
 | 
| 609 | GSK2973327 | - | - | - | - | [1]  41 41 💬
 | 
| 610 | GSK2982772 | - | - | - | - | [2]  46 46, 97 💬
 | 
| 611 | GSK2982772 60 mg | - | - | - | - | [1]  46 46 💬
 | 
| 612 | GSK2982772A, where A denotes the free base | - | - | - | - | [2]  46 46, 97 💬
 | 
| 613 | GSK3008348 | - | - | - | - | [1]  85 85 💬
 | 
| 614 | GSK3008348 Nebuliser solution | - | - | - | - | [1]  85 85 💬
 | 
| 615 | GSK3039294 | - | - | - | - | [1]  28 28 💬
 | 
| 616 | GSK3117391 | [1]  GSK-3117391 GSK-3117391 | - | - | - | [1]  46 46 💬
 | 
| 617 | GSK3152314A | - | - | - | - | [1]  46 46 💬
 | 
| 618 | GSK315234 | - | - | - | - | [1]  46 46 💬
 | 
| 619 | GSK315234 Injection 100mg/mL | - | - | - | - | [1]  46 46 💬
 | 
| 620 | GSK3196165 | - | - | - | - | [1]  46 46 💬
 | 
| 621 | GSK3196165 (Otilimab) | [1]  Otilimab Otilimab | [1]  Otilimab 
                
                    Otilimab
                
             💬
 | [1]  CSF2 CSF2 💬
 | [16]  Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | [1]  46 46 💬
 | 
| 622 | GSK3196165 Dose 1 | - | - | - | - | [1]  46 46 💬
 | 
| 623 | GSK3196165 Dose 2 | - | - | - | - | [1]  46 46 💬
 | 
| 624 | GSK3196165 Dose 3 | - | - | - | - | [1]  46 46 💬
 | 
| 625 | GSK3511294 | - | - | - | - | [2]  44 44, 45 💬
 | 
| 626 | GSK356278 | - | - | - | - | [1]  8 8 💬
 | 
| 627 | GSK3888130B | - | - | - | - | [1]  13 13 💬
 | 
| 628 | GSK706769 | - | - | - | - | [1]  46 46 💬
 | 
| 629 | GSK962040 | - | - | - | - | [1]  6 6 💬
 | 
| 630 | GSK962040 (25 mg tablet) | - | - | - | - | [1]  6 6 💬
 | 
| 631 | GT4P | [1]  Glycerol phenylbutyrate Glycerol phenylbutyrate | [1]  Glycerol phenylbutyrate 
                
                    Glycerol phenylbutyrate
                
             💬
 | - | - | [1]  251 251 💬
 | 
| 632 | GTA (Glyceryl triacetate) | [1]  Triacetin Triacetin | [1]  Triacetin 
                
                    Triacetin
                
             💬
 | - | - | [1]  307 307 💬
 | 
| 633 | GTA glyceryl triacetate | [1]  Triacetin Triacetin | [1]  Triacetin 
                
                    Triacetin
                
             💬
 | - | - | [1]  307 307 💬
 | 
| 634 | GTA: Glyceryltriacetate | - | - | - | - | [1]  307 307 💬
 | 
| 635 | GTG003.08 | - | - | - | - | [1]  65 65 💬
 | 
| 636 | GTR | - | - | - | - | [1]  13 13 💬
 | 
| 637 | GTR.ace | - | - | - | - | [1]  13 13 💬
 | 
| 638 | GTX-102 | [1]  GTX-102 GTX-102 | - | - | - | [2]  65 65, 201 💬
 | 
| 639 | GTX-102 high dose fast Period 1 and Period 2 | [1]  GTX-102 GTX-102 | - | - | - | [1]  65 65 💬
 | 
| 640 | GTX-102 low dose fast Period 1 and Period 2 | [1]  GTX-102 GTX-102 | - | - | - | [1]  65 65 💬
 | 
| 641 | GTX-102 medium dose fast Period 1 and Period 2 | [1]  GTX-102 GTX-102 | - | - | - | [1]  65 65 💬
 | 
| 642 | GTX-102 medium dose slow Period 1 and Period 2 | [1]  GTX-102 GTX-102 | - | - | - | [1]  65 65 💬
 | 
| 643 | Guaiazulene | [1]  Guaiazulen Guaiazulen | - | - | - | [1]  97 97 💬
 | 
| 644 | GUANA2015 | - | - | - | - | [1]  2 2 💬
 | 
| 645 | GUANABENZ | [1]  Guanabenz Guanabenz | [1]  Guanabenz 
                
                    Guanabenz
                
             💬
 | [3]  ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
 | [2]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [2]  2 2, 13 💬
 | 
| 646 | GUANABENZ ACETATO | [1]  Guanabenz Guanabenz | [1]  Guanabenz 
                
                    Guanabenz
                
             💬
 | [3]  ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
 | [2]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1]  2 2 💬
 | 
| 647 | Guanfacine | [1]  Guanfacine Guanfacine | [1]  Guanfacine 
                
                    Guanfacine
                
             💬
 | [1]  ADRA2A ADRA2A 💬
 | [2]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1]  193 193 💬
 | 
| 648 | Guanfacine Extended Release | [1]  Guanfacine Guanfacine | [1]  Guanfacine 
                
                    Guanfacine
                
             💬
 | [1]  ADRA2A ADRA2A 💬
 | [2]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1]  193 193 💬
 | 
| 649 | Guanfacine extended release (GXR) | [1]  Guanfacine Guanfacine | [1]  Guanfacine 
                
                    Guanfacine
                
             💬
 | [1]  ADRA2A ADRA2A 💬
 | [2]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1]  193 193 💬
 | 
| 650 | Guanidine | [1]  Guanidine Guanidine | - | - | - | [1]  113 113 💬
 | 
| 651 | Guar gum | [1]  Guar gum Guar gum | [1]  Guar gum 
                
                    Guar gum
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 652 | Gum Arabic | [1]  Acacia Acacia | [1]  Acacia 
                
                    Acacia
                
             💬
 | - | - | [1]  46 46 💬
 | 
| 653 | Guna-Anti Interleukin 1 | - | - | - | - | [1]  46 46 💬
 | 
| 654 | Guna-Antiinterleukin 1 alfa | - | - | - | - | [1]  46 46 💬
 | 
| 655 | Guna-Antiinterleukin 1 beta | - | - | - | - | [1]  46 46 💬
 | 
| 656 | Guna-Interleukin 10 | - | - | - | - | [1]  46 46 💬
 | 
| 657 | Guna-Interleukin 4 | - | - | - | - | [1]  46 46 💬
 | 
| 658 | Guselkum | - | - | - | - | [1]  97 97 💬
 | 
| 659 | GUSELKUMAB | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [5]  37 37, 41, 51, 96, 97 💬
 | 
| 660 | Guselkumab 100 mg | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  37 37 💬
 | 
| 661 | Guselkumab Dose 1 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3]  51 51, 96, 97 💬
 | 
| 662 | Guselkumab Dose 2 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3]  51 51, 96, 97 💬
 | 
| 663 | Guselkumab Dose 3 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 664 | Guselkumab Dose 4 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  96 96 💬
 | 
| 665 | Guselkumab Dose 5 | [1]  Guselkumab Guselkumab | [1]  Guselkumab 
                
                    Guselkumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  96 96 💬
 | 
| 666 | Gusperimus | [1]  Gusperimus Gusperimus | [1]  Gusperimus 
                
                    Gusperimus
                
             💬
 | - | - | [1]  44 44 💬
 | 
| 667 | Gusperimus + glucocorticoids | [1]  Gusperimus Gusperimus | [1]  Gusperimus 
                
                    Gusperimus
                
             💬
 | - | - | [1]  44 44 💬
 | 
| 668 | Gutron 2,5mg | - | - | - | - | [1]  58 58 💬
 | 
| 669 | Gutron 5mg | - | - | - | - | [1]  58 58 💬
 | 
| 670 | GVHD Prophylaxis | - | - | - | - | [2]  60 60, 65 💬
 | 
| 671 | GW-1000-02 | - | - | - | - | [1]  13 13 💬
 | 
| 672 | GW274150 | - | - | - | - | [1]  46 46 💬
 | 
| 673 | GW274150 Tablets | - | - | - | - | [1]  46 46 💬
 | 
| 674 | GW406381 | - | - | - | - | [1]  46 46 💬
 | 
| 675 | GW406381X | - | - | - | - | [1]  46 46 💬
 | 
| 676 | GW582892 | - | - | - | - | [1]  144 144 💬
 | 
| 677 | GW856553 | - | - | - | - | [1]  46 46 💬
 | 
| 678 | GWP42003 | - | - | - | - | [1]  97 97 💬
 | 
| 679 | GWP42003-P | - | - | - | - | [5]  140 140, 144, 145, 156, 158 💬
 | 
| 680 | GWP42003-P 10 mg/kg/day Dose | - | - | - | - | [1]  140 140 💬
 | 
| 681 | GWP42003-P 20 mg/kg/day Dose | - | - | - | - | [2]  140 140, 144 💬
 | 
| 682 | GWP42003-P 5 mg/kg/day Dose | - | - | - | - | [1]  140 140 💬
 | 
| 683 | GX 623 | - | - | - | - | [1]  135 135 💬
 | 
| 684 | GX CJ7 | - | - | - | - | [1]  135 135 💬
 | 
| 685 | GX-H9 | - | - | - | - | [1]  78 78 💬
 | 
| 686 | GYLENIA | - | - | - | - | [1]  13 13 💬
 | 
| 687 | GYLENIA 0,5 mg | - | - | - | - | [1]  13 13 💬
 | 
| 688 | GYM329 | - | - | - | - | [1]  3 3 💬
 | 
| 689 | GYPP-06 (GKT137831 free base), C10071301-D | - | - | - | - | [1]  93 93 💬
 | 
| 690 | GZ/SAR402671 | - | - | - | - | [2]  19 19, 67 💬
 | 
| 691 | GZ385660 | - | - | - | - | [1]  19 19 💬
 | 
| 692 | GZ402665 | - | - | - | - | [1]  19 19 💬
 | 
| 693 | GZ402666 | - | - | - | - | [1]  256 256 💬
 | 
| 694 | GZ402668 | - | - | - | - | [1]  13 13 💬
 | 
| 695 | GZ402669 | - | - | - | - | [1]  222 222 💬
 | 
| 696 | GZ402671 | - | - | - | - | [2]  19 19, 67 💬
 | 
| 697 | GZ402671 / SAR402671 | - | - | - | - | [1]  19 19 💬
 | 
| 698 | GZ402673 | - | - | - | - | [1]  13 13 💬
 | 
| 699 | GZ419829 | - | - | - | - | [1]  256 256 💬
 |